MoneyWorks4Me

The sales for the March 2026 quarter moved down -47.40% to Rs. 6088.00 millions as compared to Rs. 11574.00 millions during the year ago period.Profit after Tax for the quarter ended March 2026 saw a decline of -51.04% from Rs. 4281.00 millions to Rs. 2096.00  millions.The company reported a degrowth in operating Profit to 1653.00 millions from 6233.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 6088.00 11574.00 -47.40 35946.00 40945.00 -12.21 35946.00 40945.00 -12.21
Other Income 729.00 621.00 17.39 2811.00 3213.00 -12.51 2811.00 3213.00 -12.51
PBIDT 1653.00 6233.00 -73.48 15860.00 24656.00 -35.67 15860.00 24656.00 -35.67
Interest 97.00 88.00 10.23 323.00 196.00 64.80 323.00 196.00 64.80
PBDT 1556.00 6145.00 -74.68 15537.00 24460.00 -36.48 15537.00 24460.00 -36.48
Depreciation 456.00 937.00 -51.33 1896.00 2200.00 -13.82 1896.00 2200.00 -13.82
PBT 1100.00 5208.00 -78.88 13641.00 22260.00 -38.72 13641.00 22260.00 -38.72
TAX -996.00 927.00 -207.44 826.00 3756.00 -78.01 826.00 3756.00 -78.01
Deferred Tax -1052.00 -67.00 1470.15 -1858.00 -319.00 482.45 -1858.00 -319.00 482.45
PAT 2096.00 4281.00 -51.04 12815.00 18504.00 -30.74 12815.00 18504.00 -30.74
Equity 358.00 358.00 0.00 358.00 358.00 0.00 358.00 358.00 0.00
PBIDTM(%) 27.15 53.85 -49.58 44.12 60.22 -26.73 44.12 60.22 -26.73
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..